Detalles de la búsqueda
1.
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 385(12): 1091-1103, 2021 09 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161051
2.
Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.
Int J Clin Oncol
; 20(6): 1102-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25967286
3.
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
N Engl J Med
; 361(10): 947-57, 2009 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-19692680
4.
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.
Lancet
; 372(9652): 1809-18, 2008 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-19027483
5.
Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.
Am J Respir Crit Care Med
; 177(12): 1348-57, 2008 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18337594
6.
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.
J Clin Oncol
; 34(10): 1034-42, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26598744
7.
Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS).
J Thorac Oncol
; 6(11): 1872-80, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22011650
8.
Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).
J Clin Oncol
; 29(21): 2866-74, 2011 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21670455
9.
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial.
J Clin Oncol
; 28(5): 744-52, 2010 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20038723
10.
Mental illness: my personal experience, our professional responsibility.
J Midwifery Womens Health
; 59(4): 470, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25066746
11.
Randomized phase II study of gefitinib compared with placebo in chemotherapy-naive patients with advanced non-small-cell lung cancer and poor performance status.
J Clin Oncol
; 27(13): 2253-60, 2009 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19289623
12.
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].
J Clin Oncol
; 27(11): 1864-71, 2009 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19289630
13.
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.
J Clin Oncol
; 26(26): 4253-60, 2008 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18779612
Resultados
1 -
13
de 13
1
Próxima >
>>